Related Experiment Videos
Anticoagulation therapy in microsurgery: a review.
Morad Askari1, Christine Fisher, Frederick G Weniger
1Division of Plastic and Reconstructive Surgery, University of Southern California, Los Angeles, CA, USA.
The Journal of Hand Surgery
|May 23, 2006
Summary
Microsurgery anticoagulation lacks consensus, hindering reconstructive surgery success. This review examines current agents, risks, benefits, and future research for preventing anastomotic thrombosis.
Area of Science:
- Reconstructive Surgery
- Vascular Surgery
- Pharmacology
Background:
- Microsurgical tissue transfer and replantation have advanced reconstructive surgery.
- Anastomotic thrombosis remains a challenge, causing surgical failure in microsurgery.
- Current anticoagulation therapies for microsurgery have seen limited innovation.
Purpose of the Study:
- To review pharmacologic anticoagulation modalities in microsurgery.
- To delineate the mechanism of action and efficacy of anticoagulation agents.
- To compare risks, benefits, and human outcomes of popular anticoagulation therapies.
Main Methods:
- Literature review of major pharmacologic anticoagulation agents.
- Analysis of mechanisms of action and efficacy studies.
- Comparison of risk-benefit profiles and human outcomes data.
Main Results:
- No established consensus exists for ideal microsurgical anticoagulation protocols.
- Anastomotic thrombosis is an occasional cause of microsurgical failure.
- Review covers various agents, their efficacy, risks, and benefits.
Conclusions:
- Further research into microsurgical anticoagulation is needed.
- Optimizing anticoagulation protocols can improve reconstructive surgery outcomes.
- Future directions in microsurgical anticoagulation research are explored.